The Spine Journal is devoting an entire issue to critical reviews of published studies of Medtronic’s bone morphogenetic protein-2 product known as Infuse, a unprecedented publishing event that was prompted in part by a Milwaukee Journal Sentinel/Medpage Today investigation.

http://www.medpagetoday.com/Orthopedics/Orthopedics/27330?utm_source=breaking-news&utm_medium=email&utm_campaign=breaking-news